ea0086p183 | Bone and Calcium | SFEBES2022
Bhaskaran Divyalakshmi
, Bateman Kathryn
, Read Jordyn
, Keele Anna
Background: Cystic Fibrosis-related bone disease (CFBD) increases morbidity and mortality. Treatment varies across UK CF centres. Dual-energy X-ray absorptiometry (DEXA) is used for bone mineral density (BMD) evaluation: CFBD is diagnosed when Z-score<-2. European Cystic Fibrosis Society (ECFS) criteria for prescribing bisphosphonates:1. Presence of low-trauma fracture 2. Lumbar spine/ total hip/femoral neck Z-score <-2 and significant bone loss ...